• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Notice of Retraction and Replacement. Choi et al. Risk of hepatocellular carcinoma in patients treated with entecavir vs tenofovir for chronic hepatitis B: a Korean nationwide cohort study. JAMA Oncol. 2019;5(1):30-36.

作者信息

Lim Young-Suk, Ko Min Jung

机构信息

Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.

Division for Healthcare Technology Assessment Research, National Evidence-Based Healthcare Collaborating Agency, Seoul, Republic of Korea.

出版信息

JAMA Oncol. 2019 Jun 1;5(6):913-914. doi: 10.1001/jamaoncol.2019.0576.

DOI:10.1001/jamaoncol.2019.0576
PMID:31021386
Abstract
摘要

相似文献

1
Notice of Retraction and Replacement. Choi et al. Risk of hepatocellular carcinoma in patients treated with entecavir vs tenofovir for chronic hepatitis B: a Korean nationwide cohort study. JAMA Oncol. 2019;5(1):30-36.
JAMA Oncol. 2019 Jun 1;5(6):913-914. doi: 10.1001/jamaoncol.2019.0576.
2
Effectiveness and Safety of Entecavir or Tenofovir in a Spanish Cohort of Chronic Hepatitis B Patients: Validation of the Page-B Score to Predict Hepatocellular Carcinoma.恩替卡韦或替诺福韦在西班牙慢性乙型肝炎患者队列中的有效性和安全性：验证Page-B评分预测肝细胞癌的作用
Dig Dis Sci. 2017 Mar;62(3):784-793. doi: 10.1007/s10620-017-4448-7. Epub 2017 Jan 11.
3
Comparison of the efficacy and safety of entecavir and tenofovir in nucleos(t)ide analogue-naive chronic hepatitis B patients with high viraemia: a retrospective cohort study.恩替卡韦与替诺福韦在初治高病毒载量慢性乙型肝炎患者中的疗效和安全性比较：一项回顾性队列研究。
Clin Microbiol Infect. 2017 Jul;23(7):464-469. doi: 10.1016/j.cmi.2017.02.001. Epub 2017 Feb 9.
4
Hepatocellular carcinoma risk in HBeAg-negative chronic hepatitis B patients with or without cirrhosis treated with entecavir: HepNet.Greece cohort.恩替卡韦治疗的HBeAg阴性慢性乙型肝炎患者（无论有无肝硬化）的肝细胞癌风险：希腊HepNet队列研究
J Viral Hepat. 2015 Feb;22(2):120-7. doi: 10.1111/jvh.12283. Epub 2014 Jul 15.
5
Economic Analysis and Budget Impact of Tenofovir and Entecavir in the First-Line Treatment of Hepatitis B Virus in Italy.意大利替诺福韦和恩替卡韦一线治疗乙型肝炎病毒的经济分析和预算影响。
Appl Health Econ Health Policy. 2017 Aug;15(4):479-490. doi: 10.1007/s40258-017-0311-4.
6
Eight-year survival in chronic hepatitis B patients under long-term entecavir or tenofovir therapy is similar to the general population.长期服用恩替卡韦或替诺福韦治疗的慢性乙型肝炎患者的 8 年生存率与一般人群相似。
J Hepatol. 2018 Jun;68(6):1129-1136. doi: 10.1016/j.jhep.2018.01.031. Epub 2018 Feb 8.
7
PAGE-B predicts the risk of developing hepatocellular carcinoma in Caucasians with chronic hepatitis B on 5-year antiviral therapy.PAGE-B 预测了慢性乙型肝炎患者在接受 5 年抗病毒治疗后发生肝细胞癌的风险。
J Hepatol. 2016 Apr;64(4):800-6. doi: 10.1016/j.jhep.2015.11.035. Epub 2015 Dec 8.
8
Temporal trend and risk determinants of hepatocellular carcinoma in chronic hepatitis B patients on entecavir or tenofovir.接受恩替卡韦或替诺福韦治疗的慢性乙型肝炎患者肝细胞癌的时间趋势和风险决定因素
J Viral Hepat. 2018 May;25(5):543-551. doi: 10.1111/jvh.12832. Epub 2018 Mar 30.
9
Comparison of the efficacy of tenofovir and entecavir for the treatment of nucleos(t) ide-naïve patients with chronic hepatitis B.替诺福韦与恩替卡韦治疗初治慢性乙型肝炎患者的疗效比较
Niger J Clin Pract. 2015 Nov-Dec;18(6):796-801. doi: 10.4103/1119-3077.163296.
10
Comparison of the Efficacy of Tenofovir Versus Tenofovir plus Entecavir in the Treatment of Chronic Hepatitis B in Patients With Poor Efficacy of Entecavir: A Systematic Review and Meta-analysis.替诺福韦与替诺福韦联合恩替卡韦治疗恩替卡韦疗效不佳的慢性乙型肝炎患者的疗效比较：一项系统评价和荟萃分析
Clin Ther. 2017 Sep;39(9):1870-1880. doi: 10.1016/j.clinthera.2017.07.015. Epub 2017 Aug 7.

引用本文的文献

1
Risk of hepatocellular carcinoma in antiviral treatment-naïve chronic hepatitis B patients treated with entecavir or tenofovir disoproxil fumarate: a network meta-analysis.接受恩替卡韦或替诺福韦酯治疗的初治慢性乙型肝炎患者发生肝细胞癌的风险：一项网络荟萃分析。
BMC Cancer. 2022 Mar 17;22(1):287. doi: 10.1186/s12885-022-09413-7.